Kevin Muir

Insider Reports History

Entity
Individual
Location
C/O Delcath Systems, Inc., 1633 Broadway, Suite 22 C, New York, NY
Signature
/s/ Gerard Michel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Muir:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DELCATH SYSTEMS, INC. GM INTERVENTIONAL ONCOLOGY Common Stock 18.6K $69.1K $3.72 Mar 19, 2024 Direct
DELCATH SYSTEMS, INC. GM INTERVENTIONAL ONCOLOGY Stock Option (Right to Buy) 101K Feb 12, 2024 Direct

Insider Reports Filed by Kevin Muir

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DCTH DELCATH SYSTEMS, INC. Mar 19, 2024 1 $50K 4 Mar 19, 2024 GM INTERVENTIONAL ONCOLOGY
DCTH DELCATH SYSTEMS, INC. Feb 12, 2024 1 $0 4 Feb 14, 2024 VP COMMERCIAL OPERATIONS
DCTH DELCATH SYSTEMS, INC. Jun 12, 2023 1 $0 4 Jun 22, 2023 Vice President Commercial Operations
DCTH DELCATH SYSTEMS, INC. Feb 8, 2023 1 $0 4 Jan 26, 2024 VP COMMERCIAL OPERATIONS
DCTH DELCATH SYSTEMS, INC. May 4, 2022 0 $0 3 May 16, 2022 Vice President Commercial Operations Exhibit List: Exhibit 24 - Power of Attorney